Mortality After Rasburicase vs. Allopurinol Anti-Hyperuricemia Monotherapy in Patients With Liquid Tumors

Authors

Mitchell S. Cairo, New York Medical CollegeFollow
J R. Gallagher
E J. Drea
Y J. Barnes
C Clark
S Carroll

Author Type(s)

Faculty

Document Type

Abstract

Publication Date

10-2023

Journal Title

Annals of Oncology

Department

Pediatrics

Recommended Citation

Cairo, M. S., Gallagher, J. R., Drea, E. J., Barnes, Y. J., Clark, C., & Carroll, S. (2023). Mortality After Rasburicase vs. Allopurinol Anti-Hyperuricemia Monotherapy in Patients With Liquid Tumors. Annals of Oncology, 34 (Suppl.2), S551-S552. https://doi.org/10.1016/j.annonc.2023.09.711